Zhongshan firm wins Canadian approval

Zhongshan-based Zhongzhi Pharmaceutical Holdings has successfully obtained approval from Canada’s non-prescription and natural health product bureau for two Chinese medicinal drinks it created.

Chinese medicine are usually regarded as healthcare products or food products in overseas markets. To win approval as an OTC drug, Zhongzhi had to provide a large amount of research data to prove its safety, effectiveness and controllability, including efficacy tests, quality standard studies, homogeneity evaluation studies, research papers published at home and abroad as well as records of relevant Chinese medicines in ancient and modern books.

As more Chinese medicine companies looking to go global, following a more standardized scientific research procedure has become the industry norm.